Related Experiment Video
Updated: Aug 23, 2025

10:28
Recording Mouse Ultrasonic Vocalizations to Evaluate Social Communication
Published on: June 5, 2016
22.6K
Brain region and gene dosage-differential transcriptomic changes in Shank2-mutant mice
Ye-Eun Yoo1, Taesun Yoo1, Hyojin Kang2
1Center for Synaptic Brain Dysfunctions, Institute for Basic Science (IBS), Daejeon, South Korea.
Frontiers in Molecular Neuroscience
|October 31, 2022
Summary
Shank2 gene mutations impact brain development, causing autism spectrum disorder (ASD) and other neurodevelopmental disorders. Transcriptomic changes in Shank2-mutant mice vary by brain region and gene dosage.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Shank2 protein is crucial for excitatory synapses and linked to neurodevelopmental disorders like ASD.
- Shank2 mutations in mice cause behavioral and synaptic deficits, but regional transcriptomic effects are unclear.
Purpose of the Study:
- To investigate how brain region and Shank2 gene dosage affect transcriptomic changes in Shank2-mutant mice.
- To identify specific transcriptomic patterns in different brain regions and their relation to ASD-risk genes.
Main Methods:
- RNA-sequencing (RNA-Seq) was used for transcriptomic analysis.
- Adult Shank2 heterozygous (HT) and homozygous (HM) mutant mice lacking exons 6-7 were studied.
- Prefrontal cortex, hippocampus, and striatum were analyzed.
Main Results:
- Distinct transcriptomic patterns related to synapse, ribosome, mitochondria, spliceosome, and ECM were observed across brain regions.
- Differential expression of ASD-related and ASD-risk genes varied by brain region.
- The prefrontal cortex showed the most pronounced effects, with HT mice exhibiting increased synaptic gene expression and HM mice showing decreased synaptic gene expression.
Conclusions:
- Transcriptomic alterations in Shank2-mutant mice are specific to brain region and gene dosage.
- Findings highlight the complex genetic architecture underlying neurodevelopmental disorders associated with Shank2 mutations.

